Literature DB >> 35273810

Advanced magnetic resonance imaging findings of cerebellar hemangioblastomas: A report of three cases and a literature review.

Eiji Matsusue1, Chie Inoue1, Sadaharu Tabuchi2, Hiroki Yoshioka2, Yuichiro Nagao2, Kensuke Matsumoto1, Kazuhiko Nakamura1, Shinya Fujii3.   

Abstract

On conventional magnetic resonance imaging (MRI), hemangioblastomas typically appear as mural nodules with an adjacent surrounding cyst or a solid mass in the cerebellum. However, hemangioblastomas sometimes cannot be reliably distinguished using this imaging technique from other tumors, especially pilocytic astrocytomas and metastatic tumors, because of their similar imaging findings and locations. Herein, we report three cases of cerebellar hemangioblastomas and review their findings on conventional and advanced MRI, including diffusion-weighted imaging (DWI), dynamic susceptibility-weighted contrast-enhanced perfusion-weighted imaging (DSC-PWI), and magnetic resonance spectroscopy (MRS). Solid contrast-enhanced lesions of hemangioblastomas showed increased apparent diffusion coefficient values on DWI, increased relative cerebral blood volume ratio on DSC-PWI, and high lipid/lactate peak on MRS. Therefore, advanced MRI techniques can be helpful in understanding the pathological and metabolic changes of hemangioblastomas and may be useful for their characterization.
© The Author(s) 2022.

Entities:  

Keywords:  DWI; Hemangioblastoma; MRS; PWI; magnetic resonance imaging

Year:  2022        PMID: 35273810      PMCID: PMC8902200          DOI: 10.1177/20584601221077074

Source DB:  PubMed          Journal:  Acta Radiol Open


Introduction

Hemangioblastomas (HBs) are classified as Grade I, mesenchymal, and non-meningothelial tumors according to the World Health Organization’s classification of central nervous system tumors. They represent 1.5–2.5% of all intracranial neoplasms and 7–12% of posterior fossa tumors. Additionally, HBs are most frequently present in the cerebellar hemisphere and in individuals in their third to fifth decades of life. Moreover, 20% of cases are associated with Von Hippel–Lindau (VHL) disease. According to symptomatology, the condition is dominated by cerebellar signs of ataxia, dizziness, headache, and intracranial hypertension, which are strongly associated with tumor size and cyst mass effect.[2,4] Histologically, HBs are characterized by stromal cells with plump foamy cytoplasm and an abundant capillary network. HBs are subclassified into reticular and cellular variants.[2,5] Most HBs are the reticular variant, which shows abundant capillaries and stromal cells. The cellular variant is less common than the reticular variant and is predominantly composed of densely packed stromal cells. On conventional magnetic resonance imaging (MRI), HBs typically appear as mural nodules with an adjacent non-enhancing surrounding cyst or solid and internal and/or peripheral vessels located in the cerebellum.[6,7] However, they sometimes cannot be reliably distinguished from other tumors by conventional MRI, especially pilocytic astrocytomas (PAs) in adolescents and metastatic brain tumors (Mets) in adults, because of their similar imaging findings and locations. The application of advanced MRI techniques, including diffusion-weighted imaging (DWI),[9-12] dynamic susceptibility-weighted contrast-enhanced perfusion-weighted imaging (DSC-PWI),[8,9,11,13-15] and proton magnetic resonance (MR) spectroscopy (MRS),[8,16,17] has a better chance of assessing and distinguishing the functional and metabolic differences between HBs and other tumors. We present three cases of HB and review their findings on conventional and advanced MRI, including DWI, DSC-PWI, and MRS.

Case history

Case 1

A 35-year-old woman presented with a chief complaint of headache lasting for 2 months. Conventional MRI showed a cystic mass lesion with a mural nodule in the left cerebellar hemisphere. The mural nodule appeared as high signal intensity on T2-weighted images (T2WI) and was associated with flow voids. Moreover, the nodule was homogeneously enhanced, although the cyst wall was not enhanced. The apparent diffusion coefficient (ADC) of the nodule was 1.6 × 10−3 mm2/s. DSC-PWI showed an elevated regional cerebral blood volume (rCBV) ratio; that is, the maximal rCBV value (enhanced lesion)/the rCBV value (contralateral normal white matter) was 12.42. The intensity–time curve showed only a partial return to the baseline level due to massive leakage of contrast media into the interstitial space (Figure 1). The differential diagnoses included HB, Mets, PA, and pleomorphic xanthoastrocytoma.
Figure 1.

Representative magnetic resonance imaging findings of a 35-year-old woman with hemangioblastoma (Case 1). (a) Axial T1-weighted image (T1WI) showing a cystic mass lesion with a mural nodule in the left cerebellar hemisphere. The cystic lesion is low-intense, while the nodule (arrow) is slightly low-intense compared to the cerebellum. (b) Axial T2WI showing flow voids (arrow) in the mural nodule. (c) Axial contrast-enhanced T1WI showing homogeneous enhancement of the mural nodule (arrow) and no enhancement of the cyst wall. (d) Axial diffusion-weighted image showing that the mural nodule (arrow) is low-intense. (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule (arrow). The ADC value is 1.6 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased relative CBV (rCBV) of the nodule. The rCBV ratio, defined as the maximal rCBV (enhanced lesion in yellow circle)/rCBV (contralateral normal white matter in red circle), is 12.42. (g) The intensity–time curve showing only a partial return to the baseline level (yellow line) due to massive leakage of contrast media into the interstitial space.

Representative magnetic resonance imaging findings of a 35-year-old woman with hemangioblastoma (Case 1). (a) Axial T1-weighted image (T1WI) showing a cystic mass lesion with a mural nodule in the left cerebellar hemisphere. The cystic lesion is low-intense, while the nodule (arrow) is slightly low-intense compared to the cerebellum. (b) Axial T2WI showing flow voids (arrow) in the mural nodule. (c) Axial contrast-enhanced T1WI showing homogeneous enhancement of the mural nodule (arrow) and no enhancement of the cyst wall. (d) Axial diffusion-weighted image showing that the mural nodule (arrow) is low-intense. (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule (arrow). The ADC value is 1.6 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased relative CBV (rCBV) of the nodule. The rCBV ratio, defined as the maximal rCBV (enhanced lesion in yellow circle)/rCBV (contralateral normal white matter in red circle), is 12.42. (g) The intensity–time curve showing only a partial return to the baseline level (yellow line) due to massive leakage of contrast media into the interstitial space.

Case 2

A 32-year-old woman presented with headache, dizziness, and sensory disorders of the bilateral lower limbs. Conventional MRI revealed a nodular lesion in the left cerebellar hemisphere. The nodule appeared as slightly high signal intensity on T2WI and was associated with perifocal edema. Additionally, the nodule was homogeneously enhanced, with an ADC value of 1.3 × 10−3 mm2/s. The DSC-PWI showed increased CBV of the nodule (Figure 2), but the value could not be determined. Proton MRS with a short echo time (TE) was performed using a 3T system. The sequence, repetition time, TE, and measurement frequency were point-resolved spectroscopy, 2000 ms, 36 ms, and 128 times, respectively. A single voxel measuring 16 × 25 × 21 mm was set up, which included the edematous cerebellar region around the cerebellar enhanced nodule (Figure 2). Proton MRS revealed slightly increased lipids and/or lactate peak (Lip/Lac) between 0.9 and 1.4 ppm. The other spectra were almost normal (Figure 2). The spectra obtained from the voxel that included the edematous cerebellar parenchyma around the enhanced lesion may have reflected the tumor as well as a large part of the normal tissue. Five months later, both the nodule and perifocal edema appeared slightly enlarged on MRI. The differential diagnoses included HB, Mets, PA, and small vascular malformations.
Figure 2.

Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of a 32-year-old woman with hemangioblastoma (Case 2). (a) Axial T1-weighted image (T1WI) showing a low-intensity edematous lesion in the left cerebellar hemisphere. The nodular lesion (arrow) is unclear. (b) Axial T2WI showing a slight high-intensity nodule (arrow) with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the nodule (arrow). (d) Axial diffusion-weighted image showing that the nodule is unclear (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing slightly increased ADC of the nodule (arrow). The ADC value is 1.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased rCBV. (g) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in axial CE-T1WI (square). The VOI includes the edematous cerebellar region around the cerebellar tumor nodule. The VOI measures 16 × 25 × 21 mm. (h) The spectra showing slightly increased lipid and/or lactate peak. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost normal.

Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of a 32-year-old woman with hemangioblastoma (Case 2). (a) Axial T1-weighted image (T1WI) showing a low-intensity edematous lesion in the left cerebellar hemisphere. The nodular lesion (arrow) is unclear. (b) Axial T2WI showing a slight high-intensity nodule (arrow) with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the nodule (arrow). (d) Axial diffusion-weighted image showing that the nodule is unclear (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing slightly increased ADC of the nodule (arrow). The ADC value is 1.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased rCBV. (g) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in axial CE-T1WI (square). The VOI includes the edematous cerebellar region around the cerebellar tumor nodule. The VOI measures 16 × 25 × 21 mm. (h) The spectra showing slightly increased lipid and/or lactate peak. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost normal.

Case 3

An 84-year-old man complained of dysarthria and lightheadedness while walking. MRI revealed a mass lesion in the left cerebellar hemisphere. The lesion appeared as high signal intensity on T2WI and was associated with flow voids. Moreover, the lesion was homogeneously enhanced, and DWI showed that the mass was of low intensity. The ADC value of the nodule was 2.3 × 10−3 mm2/s. The DSC-PWI showed an elevated rCBV ratio, that is, the maximal rCBV value (enhanced lesion)/the rCBV value (contralateral normal white matter) was 12.27. The intensity–time curve showed only a partial return to the baseline level, as seen in Case 1 (Figure 3). Proton MRS with a short TE was performed using a 3T system. A single voxel of size 16 × 20 × 15 mm was set up within the mass lesion (Figure 3). The spectra obtained from the voxel that included the entire enhanced lesion reflected the tumor lesion without necrosis. MRS revealed prominent Lip/Lac between 0.9 and 1.4 ppm. Other spectra, including choline (Cho), n-acetylaspartate (NAA), and creatine peak (Cr), were almost absent (Figure 3). The differential diagnoses included HB and Mets.
Figure 3.

Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of an 84-year-old man with hemangioblastoma (Case 3). (a) Axial T1-weighted image (T1WI) showing a homogenous low-intense mass lesion (arrow) in the left cerebellar hemisphere. (b) Axial T2WI showing flow voids (arrow) in the mass lesion with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the mass lesion (arrow). (d) Axial diffusion-weighted image (DWI) showing the low-intensity mass lesion (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule. The ADC value of the circle is 2.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased CBV. The rCBV ratio, defined as the maximal rCBV (enhanced lesion—yellow circle)/rCBV (contralateral normal white matter—red circle) is 12.27. (g) The intensity–time curve showing only a partial return (yellow line) to the baseline level due to massive leakage of contrast media into the interstitial space. (h) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in the axial CE-T1WI (square). The VOI includes the entire enhanced lesion without necrosis. The VOI measures 16 × 20 × 15 mm. (i) The spectra showing prominent lipid and/or lactate peaks. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost absent.

Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of an 84-year-old man with hemangioblastoma (Case 3). (a) Axial T1-weighted image (T1WI) showing a homogenous low-intense mass lesion (arrow) in the left cerebellar hemisphere. (b) Axial T2WI showing flow voids (arrow) in the mass lesion with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the mass lesion (arrow). (d) Axial diffusion-weighted image (DWI) showing the low-intensity mass lesion (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule. The ADC value of the circle is 2.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased CBV. The rCBV ratio, defined as the maximal rCBV (enhanced lesion—yellow circle)/rCBV (contralateral normal white matter—red circle) is 12.27. (g) The intensity–time curve showing only a partial return (yellow line) to the baseline level due to massive leakage of contrast media into the interstitial space. (h) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in the axial CE-T1WI (square). The VOI includes the entire enhanced lesion without necrosis. The VOI measures 16 × 20 × 15 mm. (i) The spectra showing prominent lipid and/or lactate peaks. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost absent. A summary of the clinical data, MRI, and MRS findings for these three cases with HBs is shown in Table 1. In all cases, the tumors were completely excised and the histological diagnosis was HBs. The stromal cells were positive for inhibin-α, D2-40, and S100 in immunohistochemistry tests. VHL disease was ruled out by chest and abdominal computed tomography and fundoscopic examination in each case. The postoperative course was uneventful in all cases.
Table 1.

Summary of the clinical data and MRI and MRS findings for cerebellar hemangioblastomas.

CaseAge/sexClinical presentationOpeVHL findingsIHConventional MRI findingsADC map/ADC value (10−3 mm2/s)rCBV map/rCBV ratioLip-lacCho NAACr
135/F・HeadacheTRNegativeInhibin-α D2-40Cyst with nodule with FVIncreased/1.6Increased/12.42NANA
NA
NA
232/F・HeadacheTRNegativeInhibin-α S100Solid nodule without FVIncreased/1.3Increased/NA++
・Dizziness+
・Sensory disorders+
384/M・DysarthriaTRNegativeInhibin-α S100Solid mass with FVIncreased/2.3Increased/12.27++
・Lightheadedness

MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; Ope: operation; VHL: Von Hippel–Lindau disease; IH: positive immunohistochemistry tests for stromal cells; ADC: apparent diffusion coefficiency; rCBV: relative cerebral volume; Lip-Lac: lipid and/or lactate; Cho: choline; NAA: N-acetylaspartate; Cr: creatine; FV: flow void; TR: total resection; NA: not available; +: present; ++: elevated; –: absent.

Summary of the clinical data and MRI and MRS findings for cerebellar hemangioblastomas. MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; Ope: operation; VHL: Von Hippel–Lindau disease; IH: positive immunohistochemistry tests for stromal cells; ADC: apparent diffusion coefficiency; rCBV: relative cerebral volume; Lip-Lac: lipid and/or lactate; Cho: choline; NAA: N-acetylaspartate; Cr: creatine; FV: flow void; TR: total resection; NA: not available; +: present; ++: elevated; –: absent.

Discussion

The most common conventional MR patterns of HBs are traditionally described as enhanced mural nodules with adjacent non-enhanced surrounding cysts or enhanced solid lesions. Furthermore, HBs commonly (60–69% of cases) have associated internal and/or peripheral signal flow voids, consistent with the pathologically identified dilated afferent and efferent vessels.[6,7] Traditionally, HBs have been classified into four morphologic patterns based on macroscopic pathology. A cyst with a mural nodule type was the most common (60%), followed by a solid tumor type (26%) and a solid tumor with internal small cysts (9%), whereas a simple cyst type was the least common (5%). However, a literature review of 207 articles including 1759 infratentorial HBs over 31 years reported the solid tumor type to be the most common (47.7%), followed by the cystic (26.3%) and cystic with a mural nodule (21.3%) types. Both solid and cystic types were the least common (4.7%). Regarding the cystic component of HBs, the cyst wall is normally not neoplastic and does not show enhancement on MRI. However, there are some rare cases of HBs associated with an enhanced cystic wall, which were confirmed by histopathologic examination.[21-23] In addition, some cases of HB with MRnon-enhanced neoplastic cyst walls have been reported. In our cases, an enhanced mural nodule with an adjacent non-enhanced surrounding cyst (Case 1) and purely enhanced solid lesion (Cases 2 and 3) showed the common conventional MR patterns of HBs. Internal and peripheral signal flow voids were also observed in Cases 1 and 3. MR measurement of the rCBV derived from DSC-PWI is a useful parameter for evaluating angiogenesis in HBs. A prominent elevation of rCBV has been reported in HBs.[9,11,13-15] HBs have abundant vessels within tumors due to the overexpression of vascular endothelial growth factor, which causes a prominent increase in rCBV. rCBV ratios ranging from 7.7 to 16.65 for cerebellar HBs have been reported.[9,11,13-15] In our cases, the rCBV ratios calculated from the solid contrast-enhanced portion were 12.42% and 12.27% in Cases 1 and 3, respectively. While the small nodular enhanced lesion in Case 2 also showed increased rCBV, the value was not determined. The prominent elevations of the rCBV ratios in our cases were consistent with previous observations in HBs. DWI has been widely used for the evaluation of brain tumors. The ADC values represent the mobility of free water molecules within tissues and appear to be correlated with tumor cellularity. The ADC values for most cerebellar tumors, including Mets, are similar to or lower than those of the cerebellar parenchyma.[10,25] In contrast, increased ADC has been reported in cerebellar HBs, with values in the range of 1.27–1.55 × 10−3 mm2/s.[9-11,26] HBs are characterized by the presence of a network of capillary-like channels separated by stromal cells. The increased ADC values could be attributed to the high vascular spaces of capillaries as well as low cellular attenuation in HBs.[9,10] In contrast, cellular variants of HBs showed reduced ADC values, which may reflect the hypercellularity of stromal cells with fewer capillaries. In our cases, the ADC values obtained from the solid contrast-enhanced portion were 1.6 × 10−3 mm2/s, 1.3 × 10−3 mm2/s, and 2.3 × 10−3 mm2/s in Cases 1, 2, and 3, respectively. The differences in ADC may have resulted from the differences in their histologic findings, especially those predominantly composed of capillaries or stromal cells in HBs. MRS provides complementary metabolic and histologic marker information about brain tumors that could help in distinguishing brain tumors and tumor grading.[28,29] However, few studies have examined the MRS findings of cerebellar HBs. Prominent Lip, low creatine (Cr), absence of N-acetylaspartate (NAA), and increased choline (Cho) in HBs have been reported.[8,16,17] The presence of Lip/Lac may be associated with lipid droplets contained in the stromal cells of HBs.[2,8] Both Cases 2 and 3 showed increased Lip/Lac on MRS. In Case 3, prominent Lip/Lac and almost absent NAA, Cr, and Cho were observed. In brain tumors, the presence of Lip/Lac often indicates the presence of necrotic tissue, which is an indicator of malignancy and poor prognosis.[30,31] However, in Case 3, the spectra obtained from a voxel that included the entire enhanced lesion reflected the tumor lesion without necrosis. Several reports have shown prominent Lip/Lac for tumors without central necrosis in PAs, malignant lymphoma, meningioma, and HBs. The prominent Lip/Lac of 1.3 ppm, which is observed in malignant lymphoma, meningioma, and HBs, mainly corresponds to the Lip, whereas in PAs, it is mainly the Lac.[8,32,33] Hence, a high Lip/Lac without a necrotic component on MRS is not specific but could be a characteristic finding of HBs and may play an important role in the differential diagnosis of cerebellar tumors. The differential diagnoses of cerebellar HBs include PAs,[8,12,14,15] Mets,[9,11] arterial-venous malformation (AVM), and intracranial aneurysms[34-36] on conventional MRI. Angiography may help distinguish between AVMs and HBs. HBs may also coexist with intracranial aneurysms due to hemodynamic disturbances and chemically modulated mechanisms.[35,36] PAs in adolescents and Mets in adults are important tumors for the differential diagnosis of HBs, namely, cysts with mural nodule type mimics PAs and solid type mimics Mets. Advanced MRI techniques can help to differentiate PAs and Mets from HBs. HBs often show prominent rCBV values, increased ADC values, and high Lip/Lac without necrosis, while PAs show mildly increased rCBV ratio ranges of 1.40–1.82,[37-39] iso to increased ADC value ranges of 1.11–1.64 × 10−3 mm2/s,[26,37-39] and high Lip/Lac without necrosis.[8,32,33] Finally, Mets show mild to prominent increased rCBV ratio ranges of 2.55–10.80,[9,11,12,40-45] decreased to mildly increased ADC values ranges of 0.79–1.35 × 10−3 mm2/s,[9,11,12,41,42,44] and high Lip/Lac with necrosis.[30,31] The points for differentiation between PAs and Mets from HBs are shown in Table 2.
Table 2.

Comparisons of general imaging features of hemangioblastomas, pilocytic astrocytomas, and metastatic tumors on conventional and advanced MRI.

HemangioblastomasPilocytic astrocytomasMetastatic tumors
AgeAdultsChildrenAdults
MorphologyCyst with a mural nodule, solid, cyst, solid and cystCyst with a mural nodule, SolidSolid with necrosis
NumberSingleSingleMultiple > single
Flow voids + +
rCBVProminent increasedMild increasedMild to prominent increased
ADCIncreasedIso to increasedDecreased to mild increased
Lip/Lac+ (Lip)+ (Lac)+ (Lip/Lac)
Cho or + ++ ++
NAA +

MRI: magnetic resonance imaging; rCBV: cerebral blood volume; ADC: apparent diffusion coefficiency; Lip/Lac: lipid and/or lactate; +: present; Cho: choline; −: absent; ++: elevated; NAA: N-acetylaspartate.

Comparisons of general imaging features of hemangioblastomas, pilocytic astrocytomas, and metastatic tumors on conventional and advanced MRI. MRI: magnetic resonance imaging; rCBV: cerebral blood volume; ADC: apparent diffusion coefficiency; Lip/Lac: lipid and/or lactate; +: present; Cho: choline; −: absent; ++: elevated; NAA: N-acetylaspartate. In our cases, three advanced MRI techniques, namely, DWI, DSC-PWI, and MRS, provided characteristic information that is not available with conventional anatomic MRI alone for the imaging diagnosis of cerebellar HBs. Several studies have evaluated HBs using one of these three advanced MRI techniques,[10,13-15] few studies have evaluated the usefulness of two of the three techniques for differentiating between cerebellar HBs and other cerebellar tumors,[8,9,11,26] and no study has reported whether combining all three advanced MRI techniques could help in diagnosing HBs or more reliably differentiating HBs from other tumors. High ADC, CBV, and Lip/Lac are characteristic findings of cerebellar HBs as described above. These advanced MR imaging findings are useful in more reliable diagnosis as shown in our cases. In addition to conventional anatomical MRI, combining the results from the three advanced MRI techniques may complementarily contribute to a more accurate diagnosis of HBs. In conclusion, we presented three cases of HBs and reviewed their findings on conventional and advanced MRI, including DWI, DSC-PWI, and MRS. We observed common conventional MR patterns of HBs (cyst with mural nodule type or solid type) in each case. Moreover, solid contrast-enhanced lesions of HBs revealed increased ADC values on DWI, increased rCBV ratios on DSC-PWI, and high Lip/Lac on MRS. Advanced MRI techniques can be helpful in understanding the underlying pathological and metabolic changes of HBs and may be useful for the characterization of HBs by combining results from the three advanced MRI techniques.
  44 in total

1.  Discrimination between Glioblastoma and Solitary Brain Metastasis: Comparison of Inflow-Based Vascular-Space-Occupancy and Dynamic Susceptibility Contrast MR Imaging.

Authors:  X Li; D Wang; S Liao; L Guo; X Xiao; X Liu; Y Xu; J Hua; J J Pillai; Y Wu
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-05       Impact factor: 3.825

2.  Radiologic Features and Surgical Strategy of Hemangioblastomas with Enhanced Cyst Wall.

Authors:  Qiguang Wang; Si Zhang; Jian Cheng; Wenke Liu; Xuhui Hui
Journal:  World Neurosurg       Date:  2017-09-01       Impact factor: 2.104

3.  Posterior fossa hemangioblastomas: MR imaging.

Authors:  S R Lee; J Sanches; A S Mark; W P Dillon; D Norman; T H Newton
Journal:  Radiology       Date:  1989-05       Impact factor: 11.105

4.  Recurrent cerebellar hemangioblastoma with enhancing tumor in the cyst wall: case report.

Authors:  Frank S Bishop; James K Liu; Steven S Chin; Daniel W Fults
Journal:  Neurosurgery       Date:  2008-06       Impact factor: 4.654

5.  Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Authors:  H Poptani; R K Gupta; R Roy; R Pandey; V K Jain; D K Chhabra
Journal:  AJNR Am J Neuroradiol       Date:  1995-09       Impact factor: 3.825

6.  [Value of perfusion MRI in the study of pilocytic astrocytoma and hemangioblastoma: preliminary findings].

Authors:  F Bing; S Kremer; L Lamalle; S Chabardes; A Ashraf; B Pasquier; J-F Le Bas; A Krainik; S Grand
Journal:  J Neuroradiol       Date:  2008-10-18       Impact factor: 3.447

Review 7.  Massive hemorrhage in hemangioblastomas Literature review.

Authors:  Javier Ros de San Pedro; Fernando Alarcón Rodríguez; Belén Ferri Níguez; Juan F Martínez-Lage Sánchez; Antonio López López-Guerrero; Matías Felipe Murcia; Antonio M Ruíz-Espejo Vilar
Journal:  Neurosurg Rev       Date:  2010-01       Impact factor: 3.042

8.  Comparison of perfusion, diffusion, and MR spectroscopy between low-grade enhancing pilocytic astrocytomas and high-grade astrocytomas.

Authors:  M de Fatima Vasco Aragao; M Law; D Batista de Almeida; G Fatterpekar; B Delman; A S Bader; M Pelaez; M Fowkes; R Vieira de Mello; M Moraes Valenca
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-03       Impact factor: 3.825

9.  Differentiation of pilocytic and pilomyxoid astrocytomas using dynamic susceptibility contrast perfusion and diffusion weighted imaging.

Authors:  Chang Y Ho; Nucharin Supakul; Parth U Patel; Vetana Seit; Michael Groswald; Jeremy Cardinal; Chen Lin; Stephen F Kralik
Journal:  Neuroradiology       Date:  2019-11-01       Impact factor: 2.804

10.  Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.

Authors:  Małgorzata Neska-Matuszewska; Joanna Bladowska; Marek Sąsiadek; Anna Zimny
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

View more
  1 in total

1.  Supratentorial hemangioblastoma at the anterior skull base: A case report.

Authors:  Si-Ting Xu; Xin Cao; Xu-Yang Yin; Jing-Yi Zhang; Jin Nan; Jun Zhang
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.